To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Project Data Sphere's Data Sharing Platform

Welcome to the leading oncology open access data sharing platform. We host de-identified patient-level data contributed by industry, academia, and PDS research programs.

Register now for full access to our datasets and powerful SAS® tools, or to share your data.

Registration is quick and easy. There are no fees, and no research proposal is required.

Learn More

If you're looking for information on the Project Data Sphere organization, please visit the marketing website.

The marketing website contains information about the various research programs initiated by the Project Data Sphere organization.

PDS Platform Announcements

New Data Contribution

EMD Serono, 2 studies in Glioblastoma and 1 in Pancreatic Cancer, Dec. 2020

Eli Lilly, 1 study in Non-Small Cell Lung Cancer, Dec. 2020

G1 Therapeutics, Small Cell Lung Cancer, Nov. 2020

Our Mission

Improve outcomes for cancer patients by openly sharing data, convening world-class experts, and collaborating across industry and regulators to catalyze new scientific insights that accelerate effective treatments to patients.

Our Data

>150

Patient Level Datasets

> 100k

Patient Lives

> 16

Data Providers

> 90

Peer-Review Publications

Data is being used to drive new research and treatment methods, develop innovative technology (ML/AI models), and more efficiently plan and design clinical trials. Data contained on the PDS platform is made available through contributions from industry and key partnerships in academia, research, and government.

This data is de-identified, patient-level, randomized clinical trial data and linked or enriched data sets. To learn more about how researchers leverage the data on our platform, please visit our list of peer-reviewed journal publications.

Through an active funding partnership with the Robert Wood Johnson Foundation, PDS has been able to offer enriched randomized clinical trial data containing socio-demographic information prepared by RTI International and made available by the Agency for Healthcare Research and Quality's Medical Expenditure Panel Survey information.

SAS® Analytics Tools

Registration includes access to powerful SAS analytics tools at no cost.

Life Sciences Analytics Framework (LSAF)
Securely analyze datasets using Base SAS®, SAS/STAT®, and SAS/GRAPH®.

Visual Data Mining and Machine Learning (VDMML)
Scalable, in-memory processing environment combines data wrangling, exploration, statistical, data mining and machine learning techniques.